Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-28T05:31:16.688Z Has data issue: false hasContentIssue false
  • English
  • Français

Innovations in Electrophysiology

Published online by Cambridge University Press:  01 November 2009

Mitchell Cohen
Mitchell Cohen
Affiliation:
Section Chief, Pediatric Cardiology, Director of Electrophysiology & Pacing, Phoenix Children’s Hospital
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Article
Information
Cardiology in the Young , Volume 19 , Issue S2: Innovation associated with the treatment of patients with congenital and pediatric cardiac disease , November 2009 , pp. 48 - 53
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Villain, E, Vetter, VL, Garcia, JM, Herre, J, Cifarelli, A, Garson, A Jr. Evolving concepts in the management of congenital junctional ectopic tachycardia. Circulation 1990; 81: 1544–1549.CrossRefGoogle ScholarPubMed
2.Collins, KK, Van Hare, GF, Kertesz, NJ, Law, IH, Bar-Cohen, Y, Dubin, A, et al. Pediatric nonpost-operative junctional ectopic tachycardia. J Am Coll Cardiol 2009; 53: 690–697.CrossRefGoogle ScholarPubMed
3.Santinelli, V, Radinovic, A, Manguso, F, Vicedomini, G, Gulletta, S, Paglino, G, Mazzone, P, Ciconte, G, Sacchi, S, Sala, S, Pappone, C. The natural history of asymptomatic ventricular pre-excitation. J Am Coll Cardiol 2009; 53: 275–280.CrossRefGoogle ScholarPubMed
4.Collins, KK, Rhee, EK, Kirsh, JA, Cannon, BC, Fish, FA, Dubin, AM, Van Hare, GF. Cryoablation of accessory pathways in the coronary sinus in young patients: A multicenter study from the pediatric and Congenital Electrophysiology Society’s Working Group on Cryoablation. J Cardiovasc Electrophysiol 2007; 18: 592–597.CrossRefGoogle Scholar
5.Schwagaten, B, Jordaens, L, Witsenburg, M, Duplessis, F, Thornton, A, Van Belle, Y, Szili-Torok, T. Initial experience with catheter ablation using remote magnetic navigation in adults with complex congenital heart disease and in small children. PACE 2009; 32: S198–S201.Google Scholar
6.Peichl, P, Kautzner, J, Gebauer, R. Ablation of atrial tachycardias after correction of complex congenital heart disease: utility of intracardiac echocardiography. Europace 2009; 11: 48–53.CrossRefGoogle ScholarPubMed
7.Priori, SG, Napolitano, C, Tiso, N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196–200.CrossRefGoogle ScholarPubMed
8.Laitinen, PJ, Brown, KM, Piippo, K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485–490.CrossRefGoogle ScholarPubMed
9.Postma, AV, Denjoy, I, Hoorntje, TM, et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002; 91 (8): e21–e26.CrossRefGoogle ScholarPubMed
10.Wilde, AA, Bhuyan, ZA, Crotti, L, Facchini, M, De Ferrari, GM, Paul, T, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008; 358: 2024–2029.CrossRefGoogle ScholarPubMed
11.Schwartz, PJ, Moss, AJ, Vincent, GM, Crampton, RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993; 88: 782–784.CrossRefGoogle Scholar
12.Goldenberg, I, Moss, AJ, Peterson, DR, McNitt, S, Zareba, W, Andrews, ML, et al. Risk factors for aborted cardiac death in children with congenital long-QT syndrome. Circulation 2008; 117: 2184–2191.CrossRefGoogle ScholarPubMed
13.Locati, EH, Zareba, W, Moss, AJ, Schwartz, PJ, Vincnt, GM, Lehmann, MH, et al. Age-and sex-related differences in clinical manifestations in patients with congenital long-Qt syndrome: findings from the International LQT Registry. Circulation 1998; 97: 2237–2244.CrossRefGoogle Scholar
14.Olgun, H, Karagoz, T, Celiker, A, Ceviz, N. Patient- and lead-related factors affecting lead fracture in children with transvenous permanent pacemaker. Europace 2008; 10: 844–847.CrossRefGoogle ScholarPubMed
15.Fortescue, EB, Berul, CI, Cecchin, F, Walsh, EP, Triedman, JK, Alexander, ME. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol 2005; 14: 27–36.CrossRefGoogle ScholarPubMed
16.Sreeram, N, Gass, M, Apitz, C, Ziemer, G, Hofbeck, M, Emmel, M, et al. The diagnostic yield from implantable loop recorders in children and young adults. Clin Res Cardiol 2008; 97: 327–333.CrossRefGoogle ScholarPubMed
17.Mahajan, T, Dubin, AM, Atkins, DL, Bradley, DJ, Shannon, KM, Erickson, CC, et al. Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients. J Cardiovasc Electrophysiol 2008; 19: 1270–1274.CrossRefGoogle ScholarPubMed
18. Patient Management Recommendations for Sprint Fidelis Leads. Available at: http://www.medtronic.com/fidelis/appendixChtml. Accessed October 28, 2007.Google Scholar
19.Cantanchin, A, Anderson, L, Jones, S, et al. The higher than expected early failure rate of the Sprint Fidelis implantable cardioverter defibrillator lead (model 6949, Medtronic Inc). Heart Rhythm 2008; 5: 167–168.Google Scholar
20. Urgent medical device information. Sprint Fidelis lead patients’ management recommendations. Available at: http://www.medtronic.com/fidelis/physiican-letter.html. Accessed January 28, 2008.Google Scholar
21.Swerdlow, CD, Gunderson, BD, Ousdigian, KT, Abeyratne, A, Stadler, RW, Gillberg, JM, Patel, AS, Ellenbogen, KA. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads’. Circulation 2008; 118: 2122–2129.CrossRefGoogle ScholarPubMed
22.Danik, SB, Mansour, M, Heist, EK, Ellinor, P, Milan, D, Singh, J, et al. Timing of delayed perforation with the St. Jude Riata lead: A single-center experience and a review of the literature. Heart Rhythm 2008; 5: 1667–1672.CrossRefGoogle Scholar
23.Epstein, AE, Baker, J II, Beau, SL, Deering, TF, Greenberg, SM, Goldman, DS. Performance of the St. Jude Medical Riata leads. Heart Rhythm 2008: 1–6.CrossRefGoogle ScholarPubMed
24.Corbisiero, R, Armbrister, R. Does size really matter? A comparison of the Riata lead family based on size and its relation to performance. PACE 2008; 31: 722–726.CrossRefGoogle Scholar
25.Pham, PP, Balaji, S, Shen, I, Ungerleider, R, Li, X, Sahn, DJ. Impact of conventional versus biventricular pacing on hemodynamics and tissue Doppler imaging indexes of resynchronization postoperatively in children with congenital heart disease. J Am Coll Cardiol 2005; 46: 2284–2289.CrossRefGoogle ScholarPubMed
26.Strieper, M, Karpawich, P, Frias, P, Gooden, K, Ketchum, D, Fyfe, D, Campbell, R. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol 2004; 94: 1352–1354.CrossRefGoogle ScholarPubMed
27.Zimmerman, FJ, Starr, JP, Koenig, PR, Smith, P, Hijazi, ZM, Bacha, E. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003; 75: 1775–1780.CrossRefGoogle ScholarPubMed
28.Khairy, P, Fournier, A, Thibault, B, Dubuc, M, Theirein, J, Vobecky, SK. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol 2005; 46: 277–283.Google Scholar
29.Dubin, AM, Janousek, J, Rhee, E, Strieper, MJ, Cecchin, F, Law, IH, et al. Resynchronization therapy in pediatrics and congenital heart disease. J Am Coll Cardiol 2005; 46: 277–283.CrossRefGoogle Scholar
30.Cecchin, F, Frangini, PA, Brown, DW, Fynn-Thompson, F, Alexander, ME, Triedman, JK, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: Five years experience in a single institution. J Cardiovasc Electrophysiol 2009; 20: 58–65.CrossRefGoogle Scholar
31.Therrien, J, Siu, SC, Harris, L, Dore, A, Niwa, K, Janousek, J, Williams, WG, Webb, G, Gatzoulis, MA. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103: 2489–2494.CrossRefGoogle ScholarPubMed
32.Harrild, DM, Berul, CI, Cecchin, F, Geva, T, Gauvreau, K, Pigula, F, Walsh, EP. Pulmonary valve replacement in tetralogy of Fallot: Impact on survival and ventricular tachycardia. Circulation 2009; 119: 445–451.CrossRefGoogle ScholarPubMed